LIFE Biosystems to deploy TEMIS' clinical text analysis solution
14 October 2008
TEMIS, a leading provider of text analytics software solutions for
the life science industry, announced today that it has entered a
strategic software and services agreement with LIFE Biosystems. LIFE
Biosystems has chosen TEMIS' acclaimed Luxid for Life Sciences solution
to expedite the analysis of clinical and molecular data from diverse
textual information sources.
"Structured clinical information is essential to predictive
medicine," said Dr. Mathias Goeschl, Head of Text Mining at LIFE
Biosystems. "LIFE's commitment to understanding the causative
relationship between molecular events and patient outcomes demands an
accurate, high-performance solution for the analysis of large-scale
bibliographic information. From this perspective, Luxid provides
enhanced text mining capabilities to our existing in silico discovery
infrastructure and further supports us in generating novel clinical
insights and hypotheses."
"We are excited by the synergies created through the integration of
Luxid(R) Annotation Factory within LIFE's in silico discovery
infrastructure," said Jens Barthelmes, Life Sciences Consultant at TEMIS.
"It proves that our Life Science dedicated solution can build upon
existing computational infrastructures to provide enhanced analytical
and discovery capabilities, by extracting relationships between
biomedical entities from text. We are proud to support LIFE Biosystems
efforts in this new and exciting field of predictive medicine."
Bookmark this page